Author

Carlos Bueno‐Betí

St George's, University of LondonORCID 0000-0003-4626-1276Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:deconvolution· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Angeliki AsimakiiD· 2 shared Jeffrey E. SaffitziD· 2 shared Kory J. LavineiD· 2 shared Vinay R. PennaiD· 2 shared Abigail G. Kelly· 1 shared Alekhya ParvathaneniiD· 1 shared Ana VillanuevaiD· 1 shared Bruce D. HammockiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Angeliki AsimakiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyJACC Basic to Translational SciencePeer-reviewedMay 5, 2026

✦ In-depth digest

Interleukin-1β Drives Disease Progression in Arrhythmogenic Cardiomyopathy

Vinay R. Penna, Junedh Amrute, Morgan Engel…·Stephen P. Chelko

Human arrhythmogenic cardiomyopathy hearts harbor a lesion niche of POSTN fibroblasts and NLRP3+ inflammatory macrophages; IL-1β neutralization in Dsg2-mutant mice reduced fibrosis, dysfunction, and ventricular ectopy.

11 citationstop 1%

humanmouse

𝕏 PostBluesky

Cell BiologyJACC Basic to Translational SciencePeer-reviewedFeb 5, 2025

Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy

Dipak Panigrahy, Abigail G. Kelly, Katherine M. Quinlivan…·Jeffrey E. Saffitz

This study shows that inhibiting soluble epoxide hydrolase reduces inflammation and myocardial injury in arrhythmogenic cardiomyopathy by increasing pro-resolving lipid mediators.

8 citations

mouserat

𝕏 PostBluesky